Prostate Cancer

PCa Vaccine Followed by Docetaxel Beneficial

ANAHEIM, Calif.—Men with androgen independent prostate cancer (AIPC) who have received initial treatment with sipuleucel-T (Provenge) followed by docetaxel after progression of their disease may have prolonged survival, according to new findings presented here at the American Urological Association annual meeting.

PCa Treatment Type Affects ED Therapy

QUEBEC CITY—A Canadian study of men with erectile dysfunction (ED) following prostate cancer therapy showed that those who received radiation therapy alone had greater success with ED treatment than men treated with radical prostatectomy alone or in combination with radiation.

PCa Death Decline Tied To Screening

ANAHEIM, Calif.—Declines in prostate cancer deaths are associated with an increase in PSA screening, although the effect is greater in white than in black men, according to researchers at the University of Alabama-Birmingham.

Watchful Waiting Risks Quantified

ANAHEIM, Calif.—Fifteen percent of older men managed with watchful waiting for low-risk prostate tumors detected by PSA screening will die from the malignancy in 10 years, despite a high death rate from competing causes, a study found.

Statins Found to Decrease PSA Levels

ANAHEIM, Calif.—Statins can significantly reduce PSA levels in healthy men, and the magnitude of this decline is proportional to the extent to which the drugs reduce cholesterol levels, according to researchers.

Screening-Detected PCa May Be Less Risky

ANAHEIM, Calif.—Prostate cancers found as a result of PSA screening are less likely to exhibit extracapsular extension and positive surgical margins after radical prostatectomy than tumors found in a non-screened population, despite similar PSA levels, data show.

Active Surveillance A Viable Option for PCa

ANAHEIM, Calif.—Active surveillance with delayed intervention is a viable option for well-selected prostate cancer patients with favorable risk, according to researchers at the University of California in San Francisco.

Next post in Feature